Trials / Not Yet Recruiting
Not Yet RecruitingNCT06672601
Intra-abdominal Hypertension and Abdominal Compartment Syndrome in Patients After Pancreatic Procedures.
The HYPA Study: Intra-abdominal Hypertension and Abdominal Compartment Syndrome in Patients Undergoing Open and Robotic Pancreatic Procedures
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the development of intra-abdominal hypertension and compartment syndrome in patients undergoing elective pancreatic procedures. Main objective is to determine the proportion of patients after pancreatic operation who develop elevated intra-abdominal pressure and assess its association with postoperative complication rates. Another goal of the study is to compare open versus robotic pancreatic procedures regarding the occurrence of intra-abdominal hypertension and abdominal compartment syndrome.
Detailed description
HYPA study is designed as a prospective observational study. The primary objective of this study is to assess the risk and prevalence of intra-abdominal hypertension and abdominal compartment syndrome following pancreatic procedures. The secondary objective aims to explore potential correlations between intra-abdominal hypertension and the development of postoperative complications, such as anastomotic dehiscence, postoperative pancreatic fistulas, prolonged postoperative ileus, or delayed gastric emptying. The third objective is to compare the incidence of intra-abdominal hypertension in patients undergoing robotic versus open pancreatic procedures
Conditions
- Intra Abdominal Pressure
- Abdominal Compartment Syndrome
- Pancreatic Surgery
- Pancreatic Fistula After Pancreaticoduodenectomy
- Delayed Gastric Emptying
- Anastomotic Leaks
- Overload Fluid
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2027-12-31
- Completion
- 2028-03-31
- First posted
- 2024-11-04
- Last updated
- 2024-11-08
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT06672601. Inclusion in this directory is not an endorsement.